alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
3 r l

. 

## E;TiSsi.-3ns

# Defect Informati-vi R-r3rt

EDIR Number: 2011.02.10.07 1. Manufacturer: Hyundai Motor Company 2. description of the defect. Some 2010-2011 model year Hyundai Santa Fe vehicles may experience "bad shift feeling" which has been noted in some IQS customer surveys. To improve consumer satisfaction I lyundai will slightly modify the shift calibration for certain engine/transmission combinations to enhance the shift "smoothness" via reprogramming of the engine control module. 3. A description of vehicles potentially affected by the defect. Model Model Year Test Group 1 Santa Fe 3.5L 2010 AHYXT03.5PW5 2011 1:HYXT03.5PW5 Hyundai
4. The number of vehicles known or estimated to have the defect. The vehicles which may be affected are as below.
Model Year Model Test Group Sales Volume 2010 2011 Santa Fe 3,5L Ai lYXT03.5PW5 18,532 BHYXT03.5PW5 , * Production start T.B.D. The address of the involved plant: Montgomery and Georgia Plant, USA 5. An evaluation of the emissions and driveability impact of the defect. It is Hyundai's assessment that the subject condition does not appreciably affect emission performance and overall driveability is not affected (only shift smoothness). 6. Available emissions data which relate to the defect. No specific test data is available. 7. An indication of any anticipated manufacturer follow-up. Hyundai will publish a Technical Service : ulletin to provide repair information to Hyundai dealers for this condition and will reprogram the affected engine control modules.
```

[Congressional Bills 103th Congress]
[From the U.S. Government Publishing Office]
[H.R. 3921 Introduced in House (IH)]

103d CONGRESS
  2d Session
                                H. R. 3921

To authorize and request the President to issue a posthumous commission 
 appointing Johnson Chestnut Whittaker a second lieutenant in the Army.

_______________________________________________________________________

                    IN THE HOUSE OF REPRESENTATIVES

                           February 28, 1994

Mr. Goodlatte introduced the following bill; which was referred to the 
                      Committee on Armed Services

_______________________________________________________________________

                                 A BILL

 
To authorize and request the President to issue a posthumous commission 
 appointing Johnson Chestnut Whittaker a second lieutenant in the Army.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. REQUEST FOR POSTHUMOUS APPOINTMENT AS A COMMISSIONED OFFICER 
              IN THE ARMY.

    The President is authorized and requested to issue, or have issued, 
a posthumous commission in the name of Johnson Chestnut Whittaker of 
South Carolina in the grade of second lieutenant in the regular Army, 
as recompense for the unjust separation in the early 1880's, in 
circumstances suggesting racial prejudice, of Johnson Chestnut 
Whittaker from the Corps of Cadets of the United States Military 
Academy and from the United States Army.

SEC. 2. PROHIBITION OF BENEFITS.

    Section 1523 of title 10, United States Code, shall apply to a 
commission issued pursuant to section 1.

                                 <all>
```
<TABLE> <S> <C>

<ARTICLE>                                           5
<CIK>                                               0000924875
<NAME>                                   Shearson Mid-West Futures Fund

<S>                                                   <C>
<PERIOD-TYPE>                                       12-MOS
<FISCAL-YEAR-END>                                   DEC-31-1999
<PERIOD-START>                                      JAN-01-1999
<PERIOD-END>                                        DEC-31-1999
<CASH>                                                       44,743,618
<SECURITIES>                                                    (68,584)
<RECEIVABLES>                                                   158,229
<ALLOWANCES>                                                          0
<INVENTORY>                                                           0
<CURRENT-ASSETS>                                             44,833,263
<PP&E>                                                                0
<DEPRECIATION>                                                        0
<TOTAL-ASSETS>                                               44,833,263
<CURRENT-LIABILITIES>                                           867,817
<BONDS>                                                               0
<PREFERRED-MANDATORY>                                                 0
<PREFERRED>                                                           0
<COMMON>                                                              0
<OTHER-SE>                                                   43,965,446
<TOTAL-LIABILITY-AND-EQUITY>                                 44,833,263
<SALES>                                                               0
<TOTAL-REVENUES>                                             (9,445,706)
<CGS>                                                                 0
<TOTAL-COSTS>                                                         0
<OTHER-EXPENSES>                                              2,801,170
<LOSS-PROVISION>                                                      0
<INTEREST-EXPENSE>                                                    0
<INCOME-PRETAX>                                             (12,246,876)
<INCOME-TAX>                                                          0
<INCOME-CONTINUING>                                                   0
<DISCONTINUED>                                                        0
<EXTRAORDINARY>                                                       0
<CHANGES>                                                             0
<NET-INCOME>                                                (12,246,876)
<EPS-BASIC>                                                   (570.57)
<EPS-DILUTED>                                                         0



</TABLE>
Court of Appeals of the State of Georgia Clerk's Office, Atlanta, December 05, 2019. I certify that the above is a true extract from the minutes of the Court of Appeals of Georgia. Witness my signature and the seal of said court hereto affixed the day and year last above written. , Clerk. 

# Court of Appeals of the State of Georgia
ATLANTA, December 05, 2019 The Court of Appeals hereby passes the following order A19A1956. LANYARD DEVELOPMENT, INC. et al. v. DAVID VANGILLER.
Upon consideration of the APPELLANT'S motion FOR PERMISSION TO WITHDRAW THE APPEAL in the above styled case, it is ordered that the motion is hereby GRANTED.
EXHIBIT 32.01
 
 
 
 CERTIFICATION OF PRESIDENT PURSUANT TO
 18 U.S.C. SECTION 1350,
 AS ADOPTED PURSUANT TO
 SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
 
 
 
 
 In connection with the Annual Report of Morgan Stanley Smith Barney Spectrum Technical L.P. (the “Partnership”) on Form 10-K for the period ended December 31, 2009, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Walter Davis, President of Demeter Management LLC, the general partner of the Partnership, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to the best of my knowledge:
  (1)
The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
  (2)
The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Partnership.
  
 
 
 
 
 By:             /s/            Walter Davis
 
 Name:                                Walter Davis
 Title:                      President of Demeter Management LLC,
 general partner of the registrant
 
 Date:                      March 29, 2010
United States Court of Appeals

FOR THE EIGHTH CIRCUIT

___________

No. 97-2420

___________

David Lester, *

*

Appellant, *

*

v. *

*

John Byus, Arkansas Department of *

Correction, *

*

Appellee, *

*

Lisa A. Roger, PHP Healthcare * Appeal from the United States

Corporation, Arkansas Department of * District Court for the

Correction; H. W. Thomas, Dr., Delta * Eastern District of Arkansas.

Regional Unit, Arkansas Department * [UNPUBLISHED]

of Correction; Mark Cashion, Delta *

Regional Unit, Arkansas Department *

of Correction; Joe Ann Burnett, Delta *

Regional Unit, Arkansas Department *

of Correction, originally sued as Janet *

Burnett, *

*

Defendants. *

___________

 Submitted: January 5, 1999

 Filed: January 8, 1999

___________

Before WOLLMAN, HANSEN, and MURPHY, Circuit Judges.
The Honorable Stephen M. Reasoner, United States District Judge for the

1

Eastern District of Arkansas, adopting the report and recommendations of the

Honorable H. David Young, United States Magistrate Judge for the Eastern District

of Arkansas.

-2-

___________

PER CURIAM.

David Lester, an Arkansas inmate, appeals from the district court&s dismissal

1

of his 42 U.S.C. § 1983 action following an evidentiary hearing. Lester claimed that

defendant failed to provide him with proper medical care for an eye condition. Having

carefully reviewed the record, we conclude dismissal was proper because Lester failed

to offer evidence for holding defendant liable for the medical care he received other

than on a respondeat-superior basis. See Boyd v. Knox, 47 F.3d 966, 968 (8th Cir.

1995). Accordingly, we affirm the judgment. We deny all of Lester&s pending

motions. 

A true copy.

Attest:

CLERK, U.S. COURT OF APPEALS, EIGHTH CIRCUIT.
UNPUBLISHED UNITED STATES COURT OF APPEALS FOR THE FOURTH CIRCUIT
No. 96-7478
UNITED STATES OF AMERICA, Plaintiff - Appellee, versus WALTER ALFRED DAVIS, Defendant - Appellant.
Appeal from the United States District Court for the Eastern District of North Carolina, at Wilmington. W. Earl Britt, District Judge. (CR-93-44-BR, CA-96-30-7-BR, CA-96-145-7-BR) Submitted: February 13, 1997 Decided: February 26, 1997 Before WIDENER and HAMILTON, Circuit Judges, and BUTZNER, Senior Circuit Judge. Dismissed by unpublished per curiam opinion. Walter Alfred Davis, Appellant Pro Se. Robert Edward Skiver, Assis tant United States Attorney, Raleigh, North Carolina, for Appellee. Unpublished opinions are not binding precedent in this circuit. See Local Rule 36(c).2 PER CURIAM: Appellant seeks to appeal the district court's order denying his motion filed under 28 U.S.C. § 2255 (1994), amended by Antiterrorism and Effective Death Penalty Act of 1996, Pub. L. No. 104- 132, 110 Stat. 1214. We have reviewed the record and the district court's opinion and find no revers ible error. Accordingly, we deny a certificate of appealability and dismiss the appeal on the reasoning of the district court. United States v. Davis , Nos. CR-93-44-BR; CA-96-30-7-BR; CA-96-145-7-BR (E.D.N.C. July 1, 1996).We dispense with oral argument because the facts and legal contentions are adequately presented in the materials before the court and argument would not aid the decisional process.

DISMISSED
EXHIBIT 32.01











CERTIFICATION OF PRESIDENT PURSUANT TO


18 U.S.C. SECTION 1350,


AS ADOPTED PURSUANT TO


SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002














In connection with the Annual Report of Morgan Stanley Smith Barney Spectrum Strategic L.P. (the “Partnership”) on Form 10-K for the period ended December 31, 2009, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Walter Davis, President of Demeter Management LLC, the general partner of the Partnership, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to the best of my knowledge:




(1)
The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and




(2)
The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Partnership.



















By:             /s/        Walter Davis





Name:                    Walter Davis


Title:                      President of Demeter Management LLC,


general partner of the registrant





Date:                      March 29, 2010
UNPUBLISHED

UNITED STATES COURT OF APPEALS

FOR THE FOURTH CIRCUIT

No. 97-6354

UNITED STATES OF AMERICA,

Plaintiff - Appellee,

versus

PERSONNE ELRICO MCGHEE,

Defendant - Appellant.

Appeal from the United States District Court for the Northern District of West Virginia, at Wheeling. Frederick P. Stamp, Jr.,

Chief District Judge. (CA-96-136-5, CR-93-46)

Submitted: October 23, 1997 Decided: November 14, 1997

Before HAMILTON and WILLIAMS, Circuit Judges, and PHILLIPS, Senior

Circuit Judge.

Affirmed by unpublished per curiam opinion.

Personne Elrico McGhee, Appellant Pro Se. Paul Thomas Camilletti,

OFFICE OF THE UNITED STATES ATTORNEY, Wheeling, West Virginia, for

Appellee.

Unpublished opinions are not binding precedent in this circuit.

See Local Rule 36(c).
2

PER CURIAM:

Appellant appeals the district court's order accepting the

report and recommendation of the magistrate judge and declining to

reduce Appellant's sentence under 18 U.S.C. § 3582(c)(2) (1994). We

have reviewed the record and the district court's opinion accepting

the recommendation of the magistrate judge and find no reversible

error. Accordingly, we affirm on the reasoning of the district

court. United States v. McGhee, Nos. CR-93-46; CA-96-136-5 (N.D.W.

Va. Nov. 22, 1996). We dispense with oral argument because the

facts and legal contentions are adequately presented in the materials before the court and argument would not aid the decisional

process.

AFFIRMED
EXHIBIT 32





CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350





In connection with the quarterly Report on Form 10-Q of Constellation Growth Corporation (the “Company”) for the quarter ended March 31, 2011, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Joseph Rozelle, President of the Company, certify, pursuant to 18 U.S.C Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, to the best of my knowledge that:





1.
The Report fully complies with the requirements of Sections 13(a) or 15(d) of the Securities Exchange Act of 1934; and





2.
The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.








Date: My 13, 2011





/s/ Joseph RozelleJoseph Rozelle

President

(Principal Executive and Financial Officer)











The foregoing certification is being furnished as an exhibit to the Report pursuant to Item 601(b)(32) of Regulation S-K and  Section 906 of the Sarbanes-Oxley Act of 2002 (subsections (a) and (b) of Section 1350, Chapter 63 of Title 18, United States Code) and, accordingly, is not being filed as part of the Report for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, and is not incorporated by reference into any filings of the Company, whether made before or after the date hereof, regardless of any general incorporation language in such filing.
Test Type Report # Test System Comments Results

1-hr LC50 screen

Dupont 

26135

Rat, wholebody

Not GLP; 

Not 

Guideline

The test substance male rat, whole-body inhalation 1-hr LC50 was greater thppm as determined in an acute inhalation screen.

4-hr LC50 DuPont 17743-721 Rat, nose-only GLP; Guideline

The test substance male and female rat, nose-only inhalation 4-hr LC50 is b25,000 and 50,000 ppm. The mortality was 1/5 at the 25,000 ppm exposure the 50,000 ppm exposure was terminated due to death early in the exposure 

clinical signs. The study director believed that the animals would have died exposure to 50,000 ppm continuted. Animals recovered quickly upon termithe exposure. No adverse effects were observed at the 14,600 ppm exposure 

Cardiac sensitization DuPont 17743-1522 Dog GLP; Standard protocol The test substance cardiac sensitization no-observed-adverse-effect level NO

epinephrine challenged dogs was 70,000 ppm. Higher concentrations could tested due to the presence of clinical effects.

Bacterial reverse mutation assay (Ames) DuPont 17743-501 Bacteria GLP; Guideline The test substance was not mutagenic in the Bacterial Reverse Mutation Ass

test using Salmonella strains TA98, TA100, TA1535, and TA1537 and E. cWP2 uvr A with and without S9 activation.

In vitro chromosome aberration DuPont 17743-546 Human lymphocytes GLP; Guideline The test substance did not produce structural or numerical chromosome abe

an in vitro mammalian chromosome aberration test using human peripheral lymphocytes either in the presence or absence of S9-activated test systems.

Pilot study for 4-hr LC50 DuPont 19179-700 Rat Not GLP, Not Guideline

An inhalation 4-hr LC50 study was scheduled to be conducted in male rats. exposure was conducted to determine appropriate design concentrations for study. The exposure chamber atmosphere reached a peak concentration of 3ppm 10 minutes after the test substance vapor flow was started. During the minutes of the exposure, the animals displayed a normal startle response howactivity level decreased. As the exposure proceeded, the animals began to stremors and convulsions. By the time the chamber concentration reached 33(~10 minutes), the muscle spasms and convulsions were severe, and the studterminated at that point. 

Completed Studies CAS RN 66711-86-2 - submitted with the PMN
----

|   | (1)    | The      Report fully complies with the requirements of section 13(a) or 15(d) of      the Securities Exchange Act of 1934; and                                     |
|--------|--------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------|
|   |   |                                                                                                                                                                |
|   | (2)    | The      information contained in the Report fairly presents, in all material      respects, the financial condition and results of operations of the      Company. |

|   | /s/ William G. Miller                                     |   |
|--------|-----------------------------------------------------------|--------|
|   | William      G. Miller                                    |   |
|   | Chairman      of the Board and Co-Chief Executive Officer |   |
Order entered January 4. 2021

In t he 

### Court of Appeals Fifth District of Texas at Dallas
No. 05
- 19
- 00851
- CR DESMOND RENARD FISHER, Appellant

V. THE STATE OF TEXAS, Appellee On Appeal from the Cri mi nal District Court No. 7

Dallas County, Texas Trial Court Cause No. F19
- 00024
- Y

ORDER Before the Court is appellant’s December 29, 2020 motion for an extension of time to file his brief

. We GRANT the motion and ORDER appellant’s brief due by January 27 , 2021.

/s/ CORY L. CARLYLE JUSTICE
FW: E.O. 12866 Meeting on EGU MACT Rule 

Higgins, Cortney 

to: RobertJ Wayland, Bill Maxwell, Karen Thundiyil 

11/15/2011 09:16 AM 

Hi all, 

Consistent with our EOs, attached are the handouts from the 11/10 meeting 

on the EGU MACT rule. We will post these, along with the list of 

attendees, on our website shortly. 

 

Regards, 

Cortney 

 

-----Original Appointment----- 

From: Echols, Mabel E. 

Subject: E.O. 12866 Meeting on EGU MACT Rule 

When: Thursday, November 10, 2011 11:30 AM-12:00 PM (UTC-05:00) Eastern 

Time (US & Canada). 

Where: Room 9104 New Executive Office Building 

 

 

Randall Gerard, Podesta Group has requested this meeting. 

2060AP52_2011_11_10_Podesta_Handout1.pdf 

2060AP52_2011_11_10_Podesta_Handout2.pdf
AAP_Exhibit 10.46_12.28.2013






Exhibit 10.46


FIRST AMENDMENT TO THE
ADVANCE AUTO PARTS, INC.
EMPLOYEE STOCK PURCHASE PLAN
(As Amended and Restated Effective as of May 15, 2012)


WHEREAS, Advance Auto Parts, Inc., a Delaware Corporation, (the “Company”), sponsors the Advance Auto Parts, Inc. Employee Stock Purchase Plan (the “Plan”) to encourage and enable eligible employees of the Company and its participating subsidiaries the opportunity to acquire a proprietary interest in the Company through the purchase of the Company’s stock at a discount; and
WHEREAS, the Compensation Committee of the Board of Directors of the Company has authorized and approved an amendment of the Plan to remove the exclusion of participating rights of employees who work 20 hours or less per week.
NOW, THEREFORE, in consideration of the foregoing, Section 2(k) of the Plan is hereby amended as prescribed below, effective for quarterly stock purchase offering periods commencing on or after April 1, 2014.
SECTION 2.  DEFINITIONS.  For purposes of the Plan, the following terms shall have the following meanings:
*    *    *
(k)    “Eligible Employee” means each employee (as defined for purposes of Section 423 of the Code) of a Participating Employer who has been employed by such employer at least thirty days prior to the beginning of each Offering Period, except the following:
(i)    An employee who would own (immediately after the grant of an option under this Plan) stock possessing 5% or more of the total combined voting power or value of all classes of stock of the Company based on the rules set forth in Section 423(b)(3) and Section 424 of the Code.
(ii)    A highly compensated employee (as defined under Section 414(q) of the Code) of the Participating Employer (i) who is an officer or required to file statements under Section 16(a) of the Securities Exchange Act of 1934 or (ii) whose compensation equals or exceeds any threshold established by the Committee, if the Committee has determined in its discretion to exclude under this Plan some or all such highly compensated employees for a particular Offering Period; provided, however, that any such exclusion shall be applied in an identical manner to all highly compensated employees of every Participating Employer in that Offering Period.
*    *    *











Pursuant to the authority granted by the Compensation Committee of the Board of Directors of Advance Auto Parts, Inc. under its resolutions adopted on __________________, 2014, the undersigned hereby executes this First Amendment to the Advance Auto Parts, Inc. Employee Stock Purchase Plan on behalf of Advance Auto Parts, Inc. 




ADVANCE AUTO PARTS, INC.


By:                                                 
        Tammy Finley
        SVP, Human Resources




Dated:                                                        , 2014